Histogram-metrical DCE-MRI based Quantitative Discrimination of Breast Masses
Chao Jin1, Ting Liang1, Hongwen Du1, Gang Niu1, Zihua Su1, Peng Cao1, Yonghao Du1, Chenxia Li1, Yitong Bian1, and Jian Yang1

1Department of Radiology, the First Affiliated Hospital of Xi’an Jiaotong University, Xi'an, China, People's Republic of

Synopsis

To clarify the diagnostic efficiency of histogram and mean in tumor detection, this study aims to compare the efficiency of mean and histogram metrics (i.e. skewness, kurtosis, median, variance, entropy and energy) of Ktrans and kep at transverse slice with tumor biggest diameter in discriminating benign lesion, grade II- and III-invasive ductal carcinomas (IDC). The results indicate that in breast DCE-MRI, both mean and histogram-metrics provide roughly comparable values in identifying malignancy from benignancy. However, histogram-metrics are considerably more informative and enable to discriminate pathological grade of IDCs. kep presented better diagnostic efficiency than Ktrans.

Introduction

Breast DCE-MRI-derived pharmacokinetic metrics (e.g. Ktrans, kep and ve could quantitatively reflect the involved tissue’s microenvironment, such as tissue perfusion, vessel permeability, extracellular volume fraction and etc.1. In routine clinical works, mean with tumor biggest diameter remains a commonly-used index to identify the malignancy, while various histogram metrics like kurtosis, skewness and percentiles were studied to characterize heterogeneity of within tumor parameter maps2. Whether histogram metrics must be superior to mean in tumor detection is still unclear. Taken together, this study aims to compare the efficiency of mean and histogram metrics (i.e. skewness, kurtosis, median, variance, entropy and energy) of Ktrans and kep at transverse slice with tumor biggest diameter in discriminating benign lesion, grade II- and III-invasive ductal carcinomas (IDC) ( Figure 1).

Methods

The Internal Review Board approved this study and all the written informed consents were obtained. Patients Patients 39 patients (15 benignancy, 14 grade II- and 10 grade III-IDCs) determined by needle biopsy or/and surgical pathology were performed by DCE-MRI. MR Protocols All the MRI examinations were performed on a 3.0T MRI scanner (GE, Signa HDXT) with a 16-channel breast coil. DCE-MRIs were acquired by VIBRANT sequence (TR/TE, 4.4ms/2.1ms; FA, 15o; slice thickness, 5mm; FOV, 350mm; matrix, 416×320). Data analysis Ktrans and kep maps and quantitative metrics including mean and histogram-metrics (skewness, kurtosis, median, variance, entropy and energy) were calculated by commercially Omni-Kinetics2.0 and Matlab softwares, respectively. Statistical analysis All metrics were assessed by Wilcoxon rank-sum test. The area under the receiver operating characteristic curves (AUCs) of all metrics’ z-scores were further compared by non-parametric test.

Results

In this study, a mean and 2 histogram metrics (median and variance) of Ktrans, mean and all histogram metrics (skewness, kurtosis, median, entropy and energy) of kep showed significantly differences between benign and malignant masses (pmax=0.036) (Figure 2). With respect to IDC grading, significant differences were only found in histogram entropy and energy of kep between grade II- and III-IDC groups (entropy: median 4.38, range 3.82~4.66 v.s. median 4.54, range 4.33~4.69, p=0.0054; energy: median 0.015, range 0.011~0.03 v.s. median 0.012, range 0.01~0.016, p=0.011) (Figure 2).

In discrimination of benignancy and malignancy, the area under the ROC for mean of Ktrans was 0.73, with a best 2D mean cutoff value of 0.192 that resulted in sensitivity of 79.17% and specificity of 66.67%. While the maximal area under the ROCs for histogram metrics of Ktrans was 0.71 with a best cutoff value of 0.171 that resulted in sensitivity of 75.00% and specificity of 66.67% (Table 1). In terms of kep, the maximal areas under the ROCs for mean and histogram metrics were 0.83 and 0.91, respectively. Notably, two best cutoff values (i.e. entropy, 4.189; energy, 0.017) that yielded a higher sensitivity of 87.5% and specificity of 93.33% (Table 1). There were no significant differences between the areas under Ktrans ROCs of mean and histogram metrics (pmin=0.576); or the kep’s mean and histogram metrics (pmin=0.157). While significant differences were observed between maximal AUCs of Ktrans and kep ( p=0.011).

In respect of IDC grading, the areas under kep ROCs of histogram entropy and energy were respectively 0.84 and 0.81 (entropy: sensitivity 70%, specificity 92.86%; energy, sensitivity 80%, specificity 78.57%) ( Table 1). No significant difference was also found between the areas under kep ROCs of such two metrics (p=0.210).

Discussion

It is well-established that tumor largely depends on the angiogenesis to support its growth and progression3. In light of these, DCE-MRI derived Ktrans, kep and ve could track the changes in tumor microvasculature3. Coinciding with this fact and previous studies4, our results demonstrated the elevation of Ktrans and kep in malignant lesions than that of benign lesions. Besides, in identifying malignancy from benignancy, mean and histogram metrics of Ktrans and kep showed equivalent efficiency, whereas histogram metrics of kep showed statistically better efficiency than that of Ktrans (p=0.011) (Table 1). Such finding may lie in two aspects, one is the used population-averaged AIF that eliminated individual variations and more reflected shape of kep-related contrast agent’s wash-out curve; another is that Ktrans is more sensitive to variation in pre-contrast T1 values that may over-/under- estimate the Ktrans values5. Moreover, superior to mean, histogram metrics of kep like entropy and energy showed good discriminability in tumor grading with specificity of 92.86% (Table 1).

Conclusion

In breast DCE-MRI, both mean and histogram-metrics provide roughly comparable values in identifying malignancy from benignancy. However, histogram-metrics are considerably more informative and enable to discriminate pathological grade of IDCs. kep presented better diagnostic efficiency than Ktrans.

Acknowledgements

This work is partially supported by the National Natural Science Foundation of China (No.81171317 & 81471631), the 2011 New Century Excellent Talent Support Plan from Ministry of Education of China (NCET -11-0438) and Research Development Program for Science and Technology of Shaanxi province of China (2012K13-01-07).

References

1. Berg WA, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–849.

2. Just N. Histogram analysis of the microvasculature of intracerebral human and murine glioma xenografts. Magn Reson Med, 2011, 65(3):778–789.

3. O'Connor J P B, et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Brit J Cancer, 2007, 96(2): 189–195.

4. Li J, et al. A clinically feasible method to estimate pharmacokinetic parameters in breast cancer. Med Phys. 2009;36:3786–3794.

5. Tofts P S, Berkowitz B, Schnall M D. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med, 1995, 33(4): 564-568.

Figures

Figure 1. Histogram analysis of (A) benign tumor (female, 41 yr, breast fibroma) and (B) malignant tumor (female, 53 yr, grade III-IDC). For each, on the top are DCE MR image, Ktrans and kep maps from left to right; on the bottom are histogram contributions of Ktrans and kep values.

Figure 2. Z-scores of mean and histogram metrics of (A) Ktrans and (B) kep in discrimination of benignancy and malignancy; (C) z-scores of kep mean and histogram metrics in discrimination of grade II- and III-IDCs. * p<0.05.

Table 1. Comparison of areas under the ROCs of mean and histogram metrics: benignancy v.s. maglinancy; grade II-IDC v.s. grade III-IDC



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
2731